Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DIPHENYLAN SODIUM

PHENYTOIN SODIUM

Standard Dose
30MG PROMPT
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview DIPHENYLAN SODIUM is listed in Drugs@FDA under application 080857 (ANDA).

Marketing status: Discontinued Active ingredient PHENYTOIN SODIUM Form and strength CAPSULE;ORAL - 30MG PROMPT Sponsor CHARTWELL MOLECULAR Submission history Latest submission status date: 1985-09-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview DIPHENYLAN SODIUM is listed in Drugs@FDA under application 080857 (ANDA). Marketing status: Discontinued Active ingredient PHENYTOIN SODIUM Form and strength CAPSULE;ORAL - 30MG PROMPT Sponsor CHARTWELL MOLECULAR Submission history Latest submission status date: 1985-09-09 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.